The Reston, Va.-based contractor, which has its fiscal year on a calendar basis, also increased its full fiscal year earnings guidance to between $2.40 and $2.60 per share from its prior guidance of $2.20 to $2.45.
Revenue for the second quarter decreased 3.81 percent from the prior year period to $1.26 billion and the company raised its full fiscal year revenue guidance to between $4.8 billion and $5 billion from it prior guidance of $4.6 billion to $5 billion.
CEO Roger Krone also told investors Wednesday the company forecasts its selection with team partner Cerner (Nasdaq: CERN) and Accenture (NYSE: ACN) for the multibillion dollar commercial electronic health records contract awarded July 29 to reach what he called the “safe side” of the protest period within five days.
Leidos will offer more guidance to investors on the Defense Healthcare Management System Modernization contract after the protest period ends, Krone said.
The Wall Street consensus estimates project the company’s full fiscal 2015 earnings to be $2.44 per share and revenue to be $4.9 billion.
Shares of Leidos closed at $40.45 in New York Tuesday.